Skip to main content

Improving Protection against Influenza and Other Respiratory Pathogens: the US Flu VE Network

Agency: Centers for Disease Control and Prevention - ERA

Assistance Listings
  • 93.185 -- Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects

Forecasted opportunityLast Updated: Jul 28, 2026

Important dates

  • Forecasted post date: October 30, 2026
  • Forecasted application due date: December 31, 2026
  • Forecasted award date: August 31, 2027
  • Forecasted project start date: September 30, 2027
  • Fiscal Year: 2027

Award details

  • Expected project funding: $75,250,000
  • Expected awards: 6

Award min.

$1,350,000

Award max.

$3,550,000

  • Funding opportunity number:RFA-IP-27-026
  • Cost sharing or matching requirement:No
  • Funding instrument type:
    • Cooperative agreement
  • Opportunity Category:Discretionary
  • Opportunity Category Explanation:Not specified
  • Category of Funding Activity:
    • Health
  • Category Explanation:Not specified

History

  • Forecast posted date: July 28, 2026
  • Archive date: January 30, 2027
  • Version: 1

View version history on Grants.gov

Summary

The purpose of this notice of funding opportunity (NOFO) is to continue the work of the US Influenza Vaccine Effectiveness (Flu VE) Network. Influenza and other respiratory pathogens are important causes of morbidity, mortality, and healthcare burden across the age spectrum. This network provides evidence needed to improve the effectiveness of influenza and other respiratory pathogen vaccines. You would propose work under this NOFO to include: 1) annual VE and correlates of protection surveillance from active enrollment and systematic respiratory pathogen testing of outpatients; 2) electronic acute respiratory illness and VE surveillance; 3) household transmission research studies; and 4) immunogenicity research studies.  

This is a multi-component NOFO of Component A, B, C and D. The anticipated award number for each component is: five for Component A (VE and correlates of protection), one for Component B (Coordination and surge capacity), two for Component C (Household transmission studies) and three for Component D (Immunogenicity studies). You are required to apply for either Component A (VE and correlates of protection) or B (Coordination and surge capacity) but not both.  If you apply for Component A, you may also apply for optional Components C (Household transmission studies) or D (Immunogenicity studies) or both.  If you apply for Component B, you may also apply for optional Component D.

We expect to fund 5 sites for Component A up to $1,800,000 per site annually and 1 site for Component B up to $1,800,000 annually.  Up to 2 sites selected for Component A may be awarded optional Component C to be funded up to $1,00,000 per site annually.  Up to 3 sites selected for either Components A or B may be awarded optional Component D to be funded up to $750,000 per site annually.  

Eligibility

Education

  • Public and state institutions of higher education
  • Independent school districts
  • Private institutions of higher education

Nonprofit

  • Other Native American tribal organizations
  • Nonprofits non-higher education without 501(c)(3)
  • Nonprofits non-higher education with 501(c)(3)

Government

  • City or township governments
  • County governments
  • Special district governments
  • Federally recognized Native American tribal governments
  • State governments
  • Public and Indian housing authorities

Business

  • For-profit organizations other than small businesses

Additional information on eligibility

Not specified

Documents

No documents are currently available.

Agency contact information

Email: jpatterson@cdc.gov

jpatterson@cdc.gov

Jocelyn Patterson Mosley 404-639-6437

Link to additional information

No additional information is available

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov